Tag: FDA Draft Guidance

CHC-offLabel2

Clinical Trials Not Sufficiently Diverse – and Diversity Data Often Not Reported

CHC_DTCadvertisement1

OPDP Guidance on Presenting Risk, Efficacy Info in DTC Ads Calls for Consumer-friendly Approaches

CHC_FDA-Regulatory Images1

OPDP Plans Just One Guidance Document for 2017

Jury Says “Not Guilty” to Off-label Charges in Medical Device Case

FDA Draft Guidance Describes Framework for Electronic Submission of Promotional Materials

Social Media Master Class Helps Companies Navigate Compliance

New FDA Social Media Guidances Address Space-limited Media, Correcting Online Misinformation

FDA Denies Citizen Petition to Increase DTC Ad Font Size

PhRMA, Industry Members Object to TV Ad Review Draft Guidance